Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -10.693% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a CNC(=S)Nc1cccc(C(=O)O)c1
b Nc1cc(=O)[nH]c(SCc2ccccc2Cl)n1
c COC(=O)c1cc2c(cc1Cl)N1CCCCCC1=NS2(=O)=O
d COc1ccc(NC(=O)C2=Cc3ccccc3OC2)cc1
Answer: c. COC(=O)c1cc2c(cc1Cl)N1CCCCCC1=NS2(=O)=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1cc2c(cc1Cl)N1CCCCCC1=NS2(=O)=O
COC(=O)c1cc2c(cc1Cl)N1CCCCCC1=NS2(=O)=O
methyl2-chloro-5,5-dioxo-8,9,10,11-tetrahydro-7H-azepino[2,1-c][1,2,4]benzothiadiazine-3-carboxylate